|
Sunshine Foundation thrilled by new treatment for
Hutchinson-Gilford Progeria Syndrome (HGPS)
Foundation instrumental in
bringing international attention to HGPS in the 1980s critical for new
research

September 25, 2012
-
1041 Mill Creek Drive, Feasterville, PA 19053.
Kate Sample,
President of the Sunshine Foundation received exciting news last night
about the “First-Ever Treatment for Hutchinson Guilford Progeria
Syndrome” as announced by the Progeria Research Foundation and Boston
Children’s Hospital.
Sunshine Foundation, the original wish
granting organization, was instrumental in bringing attention to HGPS in
the 1980s. At the time, very few people were aware that this disease
existed as it occurs in only 1 out of every 12 Million births. Shortly
thereafter, Bill Sample, the
Foundation’s founder began to host annual reunions bringing together
HGPS children from all over the world for fun and fellowship. The
Foundation hosted 27 of these special events which had a goal to help
alleviate the isolation and improve life’s outlook for HGPS children and
their families.
According to Kate
Sample, “The
Sunshine Foundation is thrilled for the role it has played in offering
insight about HGPS which led to the FDA approval of a
farnesyltransferase inhibitor (FTI) aiding the treatment of children
with this often devastating disease.”
The Foundation was able to offer significant anecdotal information to
the Progeria Research Foundation about the children served in years
passed allowing approval of the cancer drug Lonafarnib in the treatment
of children with HGPS.
|